BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Policy

  Hemispherx Biopharma Files Complete Response With the FDA Regarding Its Ampligen® New Drug Application for Chronic Fatigue Syndrome

  August 1, 2012

   · 

  1 min read
• Drug Development

  InSite Vision Initiates the First Phase 3 Clinical Study of BromSite™ for the Reduction of Pain and Inflammation after Cataract Surgery

  August 1, 2012

   · 

  1 min read
• Pharm Country

  Cleveland Biolabs Inc. Announces Publication of Studies Identifying Biomarkers of CBLB502’s Efficacy as a Radiation Countermeasure

  August 1, 2012

   · 

  1 min read
• Business

  VIVUS, Inc. Announces Date of Analyst Event and Second Quarter 2012 Financial Results Conference Call

  August 1, 2012

   · 

  1 min read
• Drug Development

  Delivra™ Announces Completion of an Analytical Skin Absorption Study for LivRelief Topical Pain Relief Cream

  August 1, 2012

   · 

  1 min read
• Policy

  Depomed, Inc. Announces Submission of Serada® NDA

  August 1, 2012

   · 

  3 min read
• Business

  New York Genome Center Launches Innovation Center

  August 1, 2012

   · 

  1 min read
• Genetown

  Synageva BioPharma to Present at Upcoming Investor Conferences

  August 1, 2012

   · 

  1 min read
• Deals

  The Kedrion Group Acquires RhoGAM® Line of Products From Ortho-Clinical Diagnostics

  August 1, 2012

   · 

  5 min read
• Biotech Bay

  MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

  August 1, 2012

   · 

  3 min read